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Facial paralysis is a common condition involving the facial
nerve and can significantly impact a patient's quality of life.
The facial nerve is a compound nerve comprised of motor,
parasympathetic and sensory fibers. Damages to the facial
nerve affect facial functions and appearance. Based on the
location of the causal pathology, facial paralysis can be cate-
gorized as central or peripheral. Central facial paralysis results
from disorders of the neural system above the facial nucleus,
while peripheral facial paralysis is caused by damages to the
facial nucleus or facial nerve. Bell's palsy is the most common
peripheral facial paralysis. Diagnosis of facial paralysis is
primarily based on clinical presentation, including weak
eyebrow lifting, incomplete eye closure, drooping mouth
corner, dry eye, loss of taste sensitivity, hyperacusis and ear
pain (Stew and Williams, 2013). The etiology and degree of
facial paralysis are quite variable and so are its treatment and
treatment outcomes at this time (Kim and Lelli, 2013).* Corresponding author.
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There are roughly six types of peripheral facial paralysis:
idiopathic (Bell's palsy), congenital, infection-related, trau-
matic, tumor-related and others (Bleicher et al., 1996). Bell's
palsy has been used in lieu of “idiopathic” facial paralysis in
the past, referring to idiopathic paralysis from lower facial
neuron disorders and requiring exclusion of other etiologies
(Dale, 1973). David proposed the hypothesis that Bell's palsy
is a result of herpes virus infection, which has been supported
by some studies at serology levels (Mccormick, 2000; Musani
et al., 2009). Using polymerase chain reaction (PCR) tech-
nology, Murakami et al. (1996) was able to detect herpes virus
genes in the geniculate ganglion area in facial paralysis pa-
tients but not in normal subjects. However, as indicated by
Linder et al. (2005), detection of herpes virus in the geniculate
ganglion in facial paralysis patients itself does not necessarily
demonstrate the roles of the virus in the development of facial
paralysis. In a prospective study involving 38 patients with
Bell's palsy, specific serous IgM test showed possible infection
in 11 patients, of which 6 were borrelia burgdorferi, 4 were
chicken pox and only 1 was herpes virus (Imarhiagbe et al.,
1993). Other reported possible etiologies include zoster sine
herpete (Lee et al., 2012), Lyme disease (Oymar and Tveitnes,gy Head and Neck Surgery. Production and hosting by Elsevier (Singapore)
eativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Timing and interpretation in electrophysiological studies of facial nerve
(Bonner et al., 1991).
Test Time Results Interpretation










Excitability Test <3 weeks Threshold < 3 mA Favorable prognosis
Maximum
stimulation




8 Y. Zhao et al. / Journal of Otology 10 (2015) 7e122009), parotitis, rubella (Morgan and Nathwani, 1992),
vaccination (Mutsch et al., 2004), etc.
In adults, of all potential facial paralysis risk factors
(including diabetes and pregnancy), only aging is supported by
evidence (Monini et al., 2010). In children, Bell's palsy ap-
pears to be more common in cold seasons (Tsai et al., 2009).
Some have found that the incidence of Bell's palsy in pregnant
women is 45.1/100,000, almost three times as high as in non-
pregnant women of similar age (Hilsinger et al., 1975), and
possible causes may be hypercoagulability, elevated blood
pressure, increased fluid load, virus infection and suppressed
immunity (Cohen et al., 2000). But an analysis of these find-
ings by Vrabec et al. (2007) showed that the rate of facial
paralysis in pregnant women was not significantly higher than
in non-pregnant women and that the seemingly high rate of
facial paralysis in the third month of pregnancy might be
related to increased susceptibility to herpes virus infection
which was associated with unfavorable prognosis due to lim-
itations on pharmacological interventions during pregnancy.
3. Diagnosis
For comprehensive facial paralysis evaluation, a thorough
history must include inquiry on exposure to various viruses
(herpes, chicken pox-varicella zoster, HIV, etc) and history of
stress and cold symptoms. All categories under the House-
Brackmann grading system (H-BGS) must be covered in
physical examination. Assessment of Bell's phenomenon and
corneal reflex can help predict the risk of corneal injury. The
ear should be examined for mass or herpes rash. Head and
neck examination should include the parotid and the entire
body should be examined for erythema migrans (Melvin and
Limb, 2008). In patients with trauma to the temporal bone,
audiometric tests should be performed to assess any hearing
loss and its type and severity. Selection of imaging studies
depends on the injury in a particular patient.
Localizing tests can help determine the location of facial
nerve disorder. They are based on the fact that facial nerve
functions proximal to the site of the disorder are preserved. In
complete facial nerve damage, although localizing tests are
reliable they may not be necessary; while in partial of mixed
facial nerve injury, these tests may not be reliable and there-
fore their use is declining in recent years (Flint et al., 2010).
Electrophysiological tests include nerve excitability test,
maximum stimulation test, electroneuronography, electromy-
ography, etc, whose roles are limited in early stages of the
condition and they should be applied at different time points
(Table 1). Nerve degeneration continues in the first two weeks
in most cases of Bell's palsy (Danielides et al., 1994), and it
has therefore been recommended that nerve excitability test be
repeated during this period. Nerve excitability test and
maximum stimulation test rely on subjective observations and
can be observer-biased. In contrast, electroneuronography
(ENoG) and electromyography (EMG) are relative objective
tests. ENoG records supra-maximum stimulation evoked
compound action potentials (CAPs) from muscles and a loss
of more than 90% of amplitude compared to normal sideindicates poor prognosis. To avoid false positive results, ENoG
should be performed a few days after facial nerve injury. EMG
reflects post-synaptic potentials and can detect activities of a
single motor unit. On AY et al. evaluated the consistency be-
tween EMG and clinical assessment and found they showed
different validity levels for different areas on the face:
Kappa ¼ 0.87 for orbicularis oculi but only 0.59 for orbicu-
laris oris. In about 65% of the cases where EMG detected no
voluntary motions, their presence was reported in clinical
evaluation, although EMG detected low grade synkinesis not
noticeable to clinical assessment (On et al., 2007).
4. Management4.1. Eye protectionFacial paralysis can lead to eye closure failure, which,
without timely intervention, can result in corneal ulceration,
scarring and vision loss (Lane, 2012). Intervention is based
upon judgment on the prognosis of facial nerve function as
well as the lagophthalmos (Lee et al., 2004). For mild
lagophthalmos with optimistic prognosis, artificial tears,
ointment, humidifying cover, eyelid implant, botulinum toxin
or eyelid stitches can be effectively used. Artificial tears are
usually the first choice measure and can be combined with
ointment at night (Mavrikakis, 2008). If needed, eye patch or
humidifying cover can be added, although adding humidifying
cover has not been shown to significantly reduce the risk of
eye complications (Sorce et al., 2009). In recent years, scleral
contact lenses have been used to protect exposed cornea,
including the prosthetic replacement of the ocular surface
ecosystem (PROSE), which is a breathable scleral lens filled
with saline. Gire et al. (2013) reported using the PROSE in
patients with severe corneal complications from facial paral-
ysis which provided vision improvement with no adverse ef-
fects. Eyelid implant can reduced eye exposure while
improving appearance. Commonly used materials include gold
and platinum, with the latter often being thinner with lower
risk of protrusion or immune reactions (Bladen et al., 2012).4.2. SteroidsA British study at the end of last century showed that
among patients with Bell's palsy in England, about 36% used
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both (Rowlands et al., 2002), indicating a wide divergence
in pharmacological interventions for facial paralysis by
clinicians.
In the 2013 AAO-HNS guidelines for diagnosis and treat-
ment of Bell's palsy, oral steroids within 72 h of occurrence of
Bell's palsy are strongly recommended, while sole use of anti-
viral drugs or in patients with newly developed Bell's palsy is
advised against (Baugh et al., 2013). The 2014 guidelines by
the Canadian Bell's Palsy Task Force also recommend oral
steroids and no sole use of anti-viral medicines, although the
treatment initiation time window is reduced to within 48 h
(De Almeida et al., 2014).
A meta-analysis by De Almeida et al. (2009) that included
8 studies and a total of 1285 subjects indicated that steroids
might reduce the rate of incomplete recovery and synkinesis.
A Cochrane study involving 7 studies and 1507 subjects
showed that, after 6 months, the rate of incomplete recovery
and synkinesis in the randomly allocated treatment group was
significantly lower than the control group, although there was
no significant differences in cosmetic outcomes between the
two groups. It should be noted that a fixed effect model was
used in the variance test in this meta-analysis report with
P ¼ 0.04, suggesting a risk of forced combination effect.
From these meta-analysis studies, it appears that existing
evidence essentially supports the use of steroids in the treat-
ment of facial paralysis, which may shorten disease course and
reduce complications. It also appears that, with increasing
sample sizes, multi-center random comparative studies tend to
show positive results, but it is difficult to show statistical
significance in small sample reports.
The timing of intervention in facial paralysis has been
controversial. In a large sample random comparative study by
Mats et al. (Axelsson et al., 2011), the rate of complete
recovery in Bell's palsy was 66% (103/156) when steroids
were started within 24 h of occurrence and increased to 76%
(128/168) if initiated between 25 and 48 h (significantly
different from the control), but similar to the control when
steroids were given between 49 and 72 h (65/92 vs. 58/83,
P ¼ 0.5), indicating that steroids should be administered
within 48 h of occurrence of facial paralysis.
Steroids can not only improve prognosis in facial paralysis,
but also improve quality of life and sleep (Whitley et al.,
1996), although they do not provide pain relief (Axelsson
et al., 2011; Berg et al., 2009). Facial paralysis associated
pain usually lasts for 2 weeks followed by gradual decrease. A
report from Taiwan by Lee et al. (2013a) found that facial
paralysis was a high risk for stroke (incidence of stroke in
facial paralysis patients was 2.02 times of that in “normal”
population), and steroid therapy might lower the risk.4.3. Anti-viral therapyBased upon the hypothesis that facial paralysis may result
from viral infection, anti-viral measures have been used in
treating Bell's palsy. In a recent Cochrane systemic assessment
that included 1987 subjects, the combined results showed nosignificant differences between the anti-viral drug treated
group and placebo control group regarding facial paralysis
recovery. Compared to steroids, prognosis was worse in pa-
tients receiving anti-viral agents. The same assessment also
revealed that rate of long term complications was not signifi-
cantly different regardless if steroids or anti-viral agents were
used. The number of literature included in a web-based meta-
analysis by Numthavaj et al. (2011) is only one short of that in
the Cochrane assessment (Kawaguchi et al., 2007). Using a
mixed effects model, this report assessed efficacies of steroids
and antivirals at 3 and 6 months following facial paralysis and
showed that recovery outcomes at 3 months were significantly
worse when using acyclovir or valaciclovir alone then when
using only steroids. The authors believed that while antivirals
might have some effects in treating peripheral facial paralysis,
the effects were small. In contrast, the meta-analysis by Quant
et al. (2009), including the study by Minnerop et al. (2008) but
excluding those by Kawaguchi et al. (2007) and De Diego
et al. (1998), concluded that antivirals did not add additional
benefits in treating facial paralysis patients. In examining the
bar graphs in the report, it is clear that the inclusion of two
high quality studies (Sullivan et al., 2007; Engstrom et al.,
2008) led to their conclusion.
Acyclovir, famciclovir and valaciclovir are commonly used
antivirals. Taken orally, acyclovir is low in bioavailability
(Bentz et al., 2006), and its compliance is difficult to monitor.
Famciclovir is a prodrug of penciclovir and has high
bioavailability and long half-life inside cells when taken orally
(Lee et al., 2013b). Valaciclovir is the prodrug of acyclovir
with even higher bioavailalbility and can be dosed only twice a
day (Kawaguchi et al., 2007).4.4. Hyperbaric oxygenFacial nerve swelling inside the fallopian canal in the
temporal bone can lead to anoxia status in nerve cells (Fisch
and Felix, 1983), which is believed to be one of the mecha-
nisms in Bell's palsy. Inflammation and anoxia of the facial
nerve causes reversible neurapraxia initially, which can be
followed by Wallerian degeneration. Hyperbaric oxygen in-
creases the oxygen diffusion gradient around anoxic tissues,
which may facilitate resolution of edema and promote
regeneration (Holland et al., 2012). In studying a mouse model
of facial nerve injury, Toros et al. (2013) found that the
combination of hyperbaric oxygen and steroids resulted in
reduced axonal degeneration and blood vessel blockage and
increased axonal diameter. Racic et al. (1997) compared re-
sults of hyperbaric oxygen and prednisone treatments at 9
months follow up in 79 cases of facial paralysis and reported
rates of complete recovery of 95.2% and 75.7%, and average
recovery time of 22 and 34.4 days, respectively. They
concluded that hyperbaric oxygen yielded better outcomes
than steroids. However, the study was not blinded and there-
fore prone to study bias. Furthermore, hyperbaric therapy is
not risk free. The pressure inside a hyperbaric chamber is
1.5e3 times of atmosphere pressure and can potentially cause
round window rupture, vision change, tingling in fingers and
10 Y. Zhao et al. / Journal of Otology 10 (2015) 7e12claustrophobia, which practitioners must be aware of Plafki
et al. (2000).4.5. Electric stimulationElectrical stimulation can cause contraction of muscles that
have lost innervation (Sheffler and Chae, 2007) and promote
nerve regeneration and expression of growth-related genes
(Geremia et al., 2007). In recent years, electric stimulation has
been used in repair of injured nerves. Lal et al. (2008) estab-
lished a facial nerve electric stimulation model using rats and
found that electric stimulation significantly reduced time
needed for recovery of blink reflex. Hyv€arinen from Finland
(Hyvarinen et al., 2008) tried 6 months of skin electric stim-
ulation with gradually increased intensity in 10 patients
considered unlikely to recover (disease course longer than 1
year) and reported improvement in H-BGS scores, ENoG
findings and self-evaluation with no treatment-related adverse
incidents. But the number of cases in the study was small,
there was no controls and daily 6 h of treatment required
incredibly high compliance on the patient's part. Hyv€arinen's
findings are contradicted by conclusions in a South Africa
study (Alakram and Puckree, 2010), which reported no sig-
nificant difference in H-BGS scores between the control and
patients who received electric stimulation at an early time
following facial paralysis (<30 days). The discrepancy be-
tween the two studies may have something to do with the
timing of electric stimulation intervention. In China, Cui
(2011) established an EMG signals based functional electric
stimulation system, in which a trigger threshold was set in
reference to EMG amplitudes from auricular muscles on the
healthy side and stimulation voltage set in reference to
response of auricular muscles on the paralyzed side to electric
stimulation. As EMG potentials from contralateral auricular
muscles reached the set threshold, the system was triggered to
deliver stimulation to ipsilateral auricular muscles, causing
contraction and auricle movements synchronized to the
healthy side. Similarly, Yi et al. (2013) were able to stimulate
blink reflex using EMG signals from the contralateral side.
Regeneration following nerve injury requires multiple
processes including the survival and regrowth of neurons,
budding of nerves, as well as axonal elongation, connection
and synapses formation. It is currently believed that electric
stimulation may be able to affect the early stage of nerve
regeneration, such as the survival of neurons and budding of
nerves. Future studies need to cover the entire course of nerve
regeneration (Lal et al., 2008).4.6. Mime playDutch clinicians and mime artists first developed mime
therapies for patients with facial paralysis, which were further
developed at several German centers. To start, the patient is
instructed to massage the face and neck for 10e15 min/day,
including gentle touch and kneading that involved gentle
pulling of the paralyzed side to reduce synkinesis. The patient
is then taught to recognize facial tension and relaxation andspecific exercises to synchronize the face on both sides. The
last training session involved eye and lip closure exercises (see
description by Beurskens and Heymans (2004) for details).
Beurskens evaluated the efficacy of this therapy using the
Sunnybrook facial function grading system in 50 patients with
facial paralysis who were randomly divided into a treatment
and a control group. After 3 months, the treatment groups
showed a 20.4 points improvement compared to the control
group (Beurskens and Heymans, 2006).4.7. BiofeedbackFollowing facial paralysis, the lack of feedback from facial
movements disrupts reception of information regarding facial
motion by the brain (Baricich et al., 2012). Biofeedback helps
the brain in instant analysis and correction of facial motions.
Frequently used modalities in facial paralysis patients include
EMG and mirror feedbacks. Most studies at this time conclude
that efficacies of EMG and mirror feedbacks are similar. In a
retrospective clinical study by Dalla Toffola et al. (2012), all
subjects were assigned to groups based on disease severity and
received EMG/ENoG tests at 3e4 weeks following the onset of
their facial paralysis. EMG results indicated that recovery was
complete in those with neurapraxia, while those with sectioned
axons achieved similar recovery outcomes with either EMG or
mirror biofeedback treatments. Nakamura from Japan
(Nakamura et al., 2003) studied prevention of synkinesis by
biofeedback. Twenty seven patients with facial paralysis were
randomly divided in two groups and those in the test group were
required to move the mouth while keeping eyes equally open in
front of a mirror for 30 min every day. Assessment 10 months
later showed that the rate of synkinesis was significantly lower
in the biofeedback treatment group than in the control group.
Pourmomeny et al. (2014) also confirmed that EMG biofeed-
back might lower the rate and degree of synkinesis.4.8. AcupunctureAcupuncture has been used to treat diseases for a long time
in China, but its efficacy is yet to be proven in evidence-based
medicine. Available literature at this time mostly show that
acupuncture is effective, although all studies are blemished by
flaws like lack of randomization or blinding. Existing studies
on acupuncture are also highly heterogeneous, making com-
bined analysis difficult. To overcome this obstacle and assess
efficacy of acupuncture in Bell's palsy patients, Cumberworth
et al. (2012) performed literature search using evidence-based
medicine standards and identified 3 reports, including 2 sys-
tematic evaluations and 1 RCT. From their comparison, the
authors concluded that acupuncture might be an effective or
highly effective treatment. But for the evidence that can be
searched at this time, one should be cautious in assessing its
efficacy. Even if it is effective, differences in individual
techniques used by a particular practitioner may still result
in different efficacies. Traditionally, acupuncture therapy em-
phasizes on acquiring “Qi” to obtain the best results (Xu et al.,
2013).
11Y. Zhao et al. / Journal of Otology 10 (2015) 7e12The aim of treatment in Bell's palsy is to restore symmetry
in facial appearance and synchronized movements of facial
muscles for desired facial expressions, while protecting the
eye (Terzis and Anesti, 2011). The complexity in facial pa-
ralysis determines the complexity in its treatments, although it
also drives the development of various therapies. In the future,
management of facial paralysis should be a combined
approach encompassing patient education, drug therapies,
physiotherapies and surgical treatments.
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